Biotech, Stock

Biotech Stock Soars on Regulatory Breakthrough

04.10.2025 - 09:27:04

Regulatory Progress Sparks Investor Confidence

Shares of Applied Therapeutics continued their remarkable ascent on Friday, climbing 7.04% to close at $1.00. This performance caps an extraordinary two-week surge exceeding 130%, driven by market optimism surrounding reported progress in discussions with the U.S. Food and Drug Administration.

The catalyst for this dramatic upward move originated in late September. Market sentiment shifted significantly following indications that Applied Therapeutics and the FDA may have reached an understanding regarding a confirmatory study for a drug targeting a rare disease. This development propelled the biotech firm’s valuation substantially higher in a very short period.

This potential regulatory alignment could mark a pivotal moment for the company. The news arrives just months after Applied Therapeutics faced a notable setback in August,... Read more...

@ boerse-global.de